EDGAR Filing Documents for 0001493152-22-033252

Form 8-K - Current report:

SEC Accession No. 0001493152-22-033252

Filing Date

2022-11-22

Accepted

2022-11-22 09:10:17

Documents

Period of Report

2022-11-16

Items

Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	54264
2		ex3-1.htm	EX-3.1	12501
3		ex10-1.htm	EX-10.1	12536
4		ex10-2.htm	EX-10.2	11667
5		ex99-1.htm	EX-99.1	10385
6		ex99-1_001.jpg	GRAPHIC	4570
	Complete submission text file	0001493152-22-033252.txt		295615

Data Files

Seq	Description	Document	Type	Size
7	XBRL SCHEMA FILE	qlgn-20221116.xsd	EX-101.SCH	3236
8	XBRL LABEL FILE	qlgn-20221116_lab.xml	EX-101.LAB	34240
9	XBRL PRESENTATION FILE	qlgn-20221116_pre.xml	EX-101.PRE	22365
11	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3610

Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011

Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165

Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)